OMass Therapeutics

PITCH

Harnessing proprietary biochemistry, native mass spectrometry and custom chemistry to interrogate not just the target but how it interacts with its native ecosystem, separate from the confounding complexity of the cell

Based in

Oxford

Created in

> Website

LATEST INVESTMENT

#Biotech 05.2023

£10M

British Patient Capita